Abstract:Advanced glycation end products (AGEs) are generated by nonenzymatic modifications of macromolecules (proteins, lipids, and nucleic acids) by saccharides (glucose, fructose, and pentose) via Maillard reaction. The formed AGE molecules can be catabolized and cleared by glyoxalase I and II in renal proximal tubular cells. AGE-related diseases include physiological aging, neurodegenerative/neuroinflammatory diseases, diabetes mellitus (DM) and its complications, autoimmune/rheumatic inflammatory diseases, bone-degenerative diseases, and chronic renal diseases. AGEs, by binding to receptors for AGE (RAGEs), alter innate and adaptive immune responses to induce inflammation and immunosuppression via the generation of proinflammatory cytokines, reactive oxygen species (ROS), and reactive nitrogen intermediates (RNI). These pathological molecules cause vascular endothelial/smooth muscular/connective tissue-cell and renal mesangial/endothelial/podocytic-cell damage in AGE-related diseases. In the present review, we first focus on the cellular and molecular bases of AGE–RAGE axis signaling pathways in AGE-related diseases. Then, we discuss in detail the modes of action of newly discovered novel biomolecules and phytochemical compounds, such as Maillard reaction and AGE–RAGE signaling inhibitors. These molecules are expected to become the new therapeutic strategies for patients with AGE-related diseases in addition to the traditional hypoglycemic and anti-hypertensive agents. We particularly emphasize the importance of “metabolic memory”, the “French paradox”, and the pharmacokinetics and therapeutic dosing of the effective natural compounds associated with pharmacogenetics in the treatment of AGE-related diseases. Lastly, we propose prospective investigations for solving the enigmas in AGE-mediated pathological effects.

The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases

Advanced Glycation End-Products Acting as Immunomodulators for Chronic Inflammation, Inflammaging and Carcinogenesis in Patients with Diabetes and Immune-Related Diseases

The Clinical Relevance of Advanced Glycation Endproducts (AGE) and Recent Developments in Pharmaceutics to Reduce AGE Accumulation

Clinical/Translational Aspects of Advanced Glycation End-Products

Advanced Glycation End Products in Health and Disease

Advanced Glycation End Products and Health: A Systematic Review

AGEs and chronic subclinical inflammation in diabetes: disorders of immune system.

Inhibitory effect of phenolic compounds and plant extracts on the formation of advance glycation end products: A comprehensive review

Effects of Maillard Reaction and Its Product AGEs on Aging and Age-Related Diseases

Comprehensive research on the properties of advanced glycation end products in food and biological samples and their harmful role in inducing metabolic diseases

Receptors for Advanced Glycation End Products (RAGE): Promising Targets Aiming at the Treatment of Neurodegenerative Conditions

Underlying mechanisms and preventive strategies of advanced glycation end products in cardiovascular injury

Interactions Between Advanced Glycation End-Products (AGE) and their Receptors in the Development and Progression of Diabetic Nephropathy – are these Receptors Valid Therapeutic Targets

Protein-bound AGEs Derived from Methylglyoxal Induce Pro-Inflammatory Response and Barrier Integrity Damage in Epithelial Cells by Disrupting the Retinol Metabolism

AGE-RAGE Axis and Cardiovascular Diseases: Pathophysiologic Mechanisms and Prospects for Clinical Applications

Advanced Glycation End Products: A Comprehensive Review of Their Detection and Occurrence in Food

Advanced glycation end products in diabetic retinopathy and phytochemical therapy

Novel advances in inhibiting advanced glycation end product formation using natural compounds

A Role for Advanced Glycation End Products in Molecular Ageing

Advanced Glycation End-Products (ages) in Foods and Their Detecting Techniques and Methods: A Review

Inhibition of advance glycation end products formation, gastrointestinal digestion, absorption and toxicity: A comprehensive review